Natixis Trans Medics Group, Inc. Transaction History

Natixis

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$72.62 - $150.62 $529,181 - $1.1 Million	-7,287 Reduced 38.21%	11,786 $1.78 Million
Q1 2024 May 13, 2024	SELL	$70.86 - $89.93 $352,315 - $447,131	-4,972 Reduced 20.68%	19,073 $1.41 Million
Q4 2023 Feb 13, 2024	SELL	$36.74 - $81.08 $209,858 - $463,128	-5,712 Reduced 19.2%	24,045 $1.9 Million
Q3 2023 Nov 14, 2023	SELL	$53.47 - $96.07 $252,645 - $453,930	-4,725 Reduced 13.7%	29,757 $1.63 Million
Q2 2023 Aug 11, 2023	SELL	$66.23 - $88.73 $12,981 - $17,391	-196 Reduced 0.57%	34,482 $2.9 Million
Q1 2023 May 12, 2023	SELL	$53.63 - $82.33 $1.97 Million - $3.02 Million	-36,710 Reduced 51.42%	34,678 $2.63 Million
Q4 2022 Feb 24, 2023	BUY	$39.08 - $64.29 $1.39 Million - $2.29 Million	35,675 Added 99.89%	71,388 $4.41 Million
Q4 2022 Feb 13, 2023	SELL	$39.08 - $64.29 $50,139 - $82,484	-1,283 Reduced 3.47%	35,713 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $273,814 - $483,687	8,676 Added 30.64%	36,996 $1.62 Million
Q2 2022 Aug 12, 2022	BUY	$20.56 - $32.15 $582,259 - $910,488	28,320 New	28,320 $860,000

347

30.6M

671K

858K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.15B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.